Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 117 hits in this display
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Ki: 0.380nMAssay Description:Inhibition of CK2alpha (unknown origin) using RRRADDSDDDDD as substrate in presence of [gamma33P]-ATP by autoradiographyMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 0.5nMAssay Description:Displacement of 5-TAMRA-labeled ARC-1530 from CK2alpha (unknown origin) (1 to 335 residues) after 15 to 60 mins by luminescence assayMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 4nMAssay Description:Inhibition of N-terminal GST-tagged human CLK2 (138 to end residues) using SR-rich substrate and [gamma-33P]ATP incubated for 40 mins by scintillatio...More data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 11nMAssay Description:Inhibition of GST-tagged human CK2alpha' (1 to 350 residues) using CK2tide as substrate incubated for 1 hr by off-chip mobility shift assayMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 19nMAssay Description:Inhibition of GST-tagged human CK2alpha (1 to 391 residues) using CK2tide as substrate incubated for 1 hr by off-chip mobility shift assayMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 20nMAssay Description:Inhibition of CK2alpha (unknown origin) (1 to 335 residues) using 5-TAMRA-RADDSDDDDD as substrate after 30 mins by fluorescence imaging methodMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 56nMAssay Description:Inhibition of recombinant human CDK1/cyclin B in presence of ATP at Km concentration by radiometric filter-binding assayMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 1.00E+3nMAssay Description:Inhibition of CK2 in human 786-0 cells assessed as decrease in Akt1 phosphorylation at Ser129 after 24 hrs by Western blot analysisMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 1.00E+3nMAssay Description:Inhibition of CK2 in human 786-0 cells assessed as decrease in Akt1 phosphorylation at Ser129 after 24 hrs by Western blot analysisMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 1.80E+3nMAssay Description:Inhibition of CDK2/cyclin E (unknown origin) expressed in Sf9 cells using histone H1 as substrate in presence of [gamma33P]ATPMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 2.00E+3nMAssay Description:Inhibition of CK2alpha (unknown origin) assessed as reduction in GST-Six1 phosphorylation in presence of ATP by radiometric kinase assayMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 2.00E+3nMAssay Description:Inhibition of CK2alpha (unknown origin) assessed as reduction in GST-Six1 phosphorylation in presence of ATP by radiometric kinase assayMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 2.00E+3nMAssay Description:Inhibition of CK2alpha (unknown origin) assessed as reduction in nucleolin phosphorylation in presence of ATP by radiometric kinase assayMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
IC50: 2.00E+3nMAssay Description:Inhibition of CK2alpha (unknown origin) assessed as reduction in nucleolin phosphorylation in presence of ATP by radiometric kinase assayMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Kd: 0.560nMAssay Description:Inhibition of ARC-1504 binding to CK2alpha (unknown origin) (1 to 335 residues) measured after 15 mins by fluorescence anisotropic methodMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Kd: 0.562nMAssay Description:Inhibition of ARC-1504 binding to CK2alpha (unknown origin) (1 to 335 residues) measured after 15 mins by fluorescence anisotropic methodMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
EC50: 1.00E+3nMAssay Description:Inhibition of CK2 in human 786-0 cells assessed as decrease in alpha-catenin phosphorylation at Ser641 after 24 hrs by Western blot analysisMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
EC50: 1.00E+3nMAssay Description:Inhibition of CK2 in human 786-0 cells assessed as decrease in alpha-catenin phosphorylation at Ser641 after 24 hrs by Western blot analysisMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
EC50: 5.30E+3nMAssay Description:Inhibition of CK2 in human 786-0 cells assessed as reduction in STAT3 phosphorylation at Y705 after 24 hrs by Western blot analysisMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
EC50: 5.30E+3nMAssay Description:Inhibition of CK2 in human 786-0 cells assessed as reduction in STAT3 phosphorylation at Y705 after 24 hrs by Western blot analysisMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Kd: 1.80nMAssay Description:Binding affinity to human C-terminal his tagged DYRK1A (26 to 490 residues) expressed in Escherichia coli at 5 uM by radiometric analysisMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Kd: 38nMAssay Description:Binding affinity to human C-terminal his tagged GSK3beta (26 to 383 residues) expressed in Escherichia coli at 12.5 uM by radiometric analysisMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Kd: 35nMAssay Description:Binding affinity to human C-terminal his tagged DYRK1A (26 to 490 residues) expressed in Escherichia coli assessed as apparent dissociation constantMore data for this Ligand-Target Pair
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
BDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Displayed 1 to 50 (of 117 total ) | Next | Last >>